Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Select Medical Holdings (SEM) over the last 17 years, with Q3 2025 value amounting to $11.7 million.

  • Select Medical Holdings' Gains from Investment Securities fell 7200.14% to $11.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.3 million, marking a year-over-year decrease of 3495.71%. This contributed to the annual value of $133.2 million for FY2024, which is 5047.68% up from last year.
  • As of Q3 2025, Select Medical Holdings' Gains from Investment Securities stood at $11.7 million, which was down 7200.14% from $10.9 million recorded in Q2 2025.
  • Select Medical Holdings' 5-year Gains from Investment Securities high stood at $64.5 million for Q2 2021, and its period low was $7.4 million during Q4 2022.
  • Moreover, its 5-year median value for Gains from Investment Securities was $12.4 million (2024), whereas its average is $25.2 million.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first surged by 121526.22% in 2021, then tumbled by 8614.12% in 2022.
  • Quarter analysis of 5 years shows Select Medical Holdings' Gains from Investment Securities stood at $44.3 million in 2021, then tumbled by 83.2% to $7.4 million in 2022, then soared by 34.41% to $10.0 million in 2023, then skyrocketed by 204.67% to $30.5 million in 2024, then plummeted by 61.55% to $11.7 million in 2025.
  • Its Gains from Investment Securities stands at $11.7 million for Q3 2025, versus $10.9 million for Q2 2025 and $20.1 million for Q1 2025.